GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » Return-on-Tangible-Equity
中文

Prenetics Global (Prenetics Global) Return-on-Tangible-Equity : -31.52% (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Prenetics Global Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Prenetics Global's annualized net income for the quarter that ended in Sep. 2023 was $-54.3 Mil. Prenetics Global's average shareholder tangible equity for the quarter that ended in Sep. 2023 was $172.2 Mil. Therefore, Prenetics Global's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2023 was -31.52%.

The historical rank and industry rank for Prenetics Global's Return-on-Tangible-Equity or its related term are showing as below:

PRE' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -64.77   Med: -64.77   Max: -24.02
Current: -24.02

During the past 4 years, Prenetics Global's highest Return-on-Tangible-Equity was -24.02%. The lowest was -64.77%. And the median was -64.77%.

PRE's Return-on-Tangible-Equity is ranked worse than
64.04% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: -0.63 vs PRE: -24.02

Prenetics Global Return-on-Tangible-Equity Historical Data

The historical data trend for Prenetics Global's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prenetics Global Return-on-Tangible-Equity Chart

Prenetics Global Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Return-on-Tangible-Equity
- -64.77 - -

Prenetics Global Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.76 3.26 -22.58 -50.22 -31.52

Competitive Comparison of Prenetics Global's Return-on-Tangible-Equity

For the Diagnostics & Research subindustry, Prenetics Global's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prenetics Global's Return-on-Tangible-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prenetics Global's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Prenetics Global's Return-on-Tangible-Equity falls into.



Prenetics Global Return-on-Tangible-Equity Calculation

Prenetics Global's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2022 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-190.453/( (-428.614+188.478 )/ 2 )
=-190.453/-120.068
=N/A %

Prenetics Global's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=-54.28/( (167.405+176.96)/ 2 )
=-54.28/172.1825
=-31.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Prenetics Global  (NAS:PRE) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Prenetics Global Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Prenetics Global's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Prenetics Global (Prenetics Global) Business Description

Traded in Other Exchanges
N/A
Address
Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.